BostonGene
PrivateLast Round
Series B
Apr 6, 2022
Est. Valuation
$2B
Total Funding Raised
$200M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BostonGene is a biotechnology company that develops an AI-powered, omnimodal analysis platform that integrates genomic, transcriptomic, immune, and clinical data to provide actionable insights for oncology drug development and personalized patient care.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Medical AI, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BostonGene Comparables
Compare BostonGene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tempus | 83% | |
| Caris Life Sciences | 80% | |
| ConcertAI | 76% | |
BostonGene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 6, 2022 | ||||
| Series A | Apr 24, 2019 |
Key People
Founding team and executive leadership
BostonGene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Industrial Partners | Series B |
| Impact Investment Exchange | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Launched an AI foundation model for tumor and immune biology.
- May 17, 2026
Launched Liquid BiopsyTM clinical report.
BostonGene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BostonGene's valuation, stock price, and market status.